This case report describes a case of pseudonormokalemia, true hypokalemia. Often, only laboratory values outside the normal range gain attention and false normal results are at risk of not being noticed. However, a disease state may be masked by another pathological process. Here, a 50-year old male was admitted to the Department of Internal Medicine due to sepsis from a dental infection. Initially, serum potassium measurement revealed a normal value of 4 mmol/L (reference interval 3.8-5.1 mmol/L). Thrombocyte number was above 500x109/L. Due to our policy to recommend a repeated measurement of potassium in whole blood or heparin plasma if a patient has thrombocytosis, pseudonormokalemia was identified because the heparin plasma potassium value was only 2.9 mmol/L (reference interval 3.5-4.8 mmol/L). The physiological difference between serum and plasma concentration is no more than 0.3 mmol/L. In this case, potassium concentration were falsely elevated in the serum sample, probably caused by the high number of platelets releasing potassium during clotting. Interpretative comments in patients with thrombocytosis over 500x109/L recommending plasma potassium measurement are helpful. The best way to eliminate pseudohyperkalemia and pseudonormokalemia phenomena caused by thrombocytosis is to completely change towards heparin plasma as the standard material.

Department of Clinical Biochemistry and Pharmacology The Tomas Bata Hospital in Zlín Zlín Czechia

Institute of Laboratory Medicine Medical Faculty University of Ostrava Ostrava Czechia

Zobrazit více v PubMed

Schumacher GE, Barr JT. Total testing process applied to therapeutic drug monitoring: impact on patients’ outcomes and economics. Clin Chem. 1998;44:370–4. 10.1093/clinchem/44.2.370 PubMed DOI

Zacchia M, Abategiovanni ML, Stratigis S, Capasso G. Potassium: From Physiology to Clinical Implications. Kidney Dis (Basel). 2016;2:72–9. 10.1159/000446268 PubMed DOI PMC

Schlüter K, Cadamuro J. Erroneous potassium results: preanalytical causes, detection, and corrective actions. Crit Rev Clin Lab Sci. 2023;60:442–65. 10.1080/10408363.2023.2195936 PubMed DOI

Lippi G, Cadamuro J. Visual assessment of sample quality: quo usque tandem? Clin Chem Lab Med. 2018;56:513–5. 10.1515/cclm-2017-0867 PubMed DOI

Clase CM, Carrero JJ, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020;97:42–61. 10.1016/j.kint.2019.09.018 PubMed DOI

Thurlow V, Ozevlat H, Jones SA, Bailey IR. Establishing a practical blood platelet threshold to avoid reporting spurious potassium results due to thrombocytosis. Ann Clin Biochem. 2005;42:196–9. 10.1258/0004563053857761 PubMed DOI

Sevastos N, Theodossiades G, Archimandritis AJ. Pseudohyperkalemia in serum: a new insight into an old phenomenon. Clin Med Res. 2008;6:30–2. 10.3121/cmr.2008.739 PubMed DOI PMC

Ranjitkar P, Greene DN, Baird GS, Hoofnagle AN, Mathias PC. Establishing evidence-based thresholds and laboratory practices to reduce inappropriate treatment of pseudohyperkalemia. Clin Biochem. 2017;50:663–9. 10.1016/j.clinbiochem.2017.03.007 PubMed DOI

Šálek T. Pseudohyperkalemia - Potassium released from cells due to clotting and centrifugation - a case report. Biochem Med (Zagreb). 2018;28:011002. 10.11613/BM.2018.011002 PubMed DOI PMC

Delgado JA, Lopez B, Morell-García D, Martínez-Morillo E, Antonieta Ballesteros M, Jiménez SA, et al. Clinical Thresholds for Pseudohyperkalemia and Pseudonormokalemia in Patients with Thrombocytosis. EJIFCC. 2022;33:233–41. PubMed PMC